|
|
Volumn 503, Issue 2-3, 2001, Pages 219-220
|
|
In vitro antitumor activity of cerivastatin, a novel and potent HMG-CoA reductase inhibitor [2]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
ANTILIPEMIC AGENT;
ANTINEOPLASTIC AGENT;
CERIVASTATIN;
ENDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEVALONIC ACID;
MEVINOLIN;
ONCOPROTEIN;
PROTEIN RAS;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
ANGIOGENESIS;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
BLADDER CARCINOMA;
COLON ADENOCARCINOMA;
CONCENTRATION RESPONSE;
CYTOTOXICITY;
HISTIOCYTIC LYMPHOMA;
HUMAN;
LETTER;
LYMPHOMA;
MELANOMA;
METASTASIS;
MUTATION;
NONHUMAN;
OVARY ADENOCARCINOMA;
PANCREAS CARCINOMA;
PLEIOTROPY;
PRIORITY JOURNAL;
TUMOR CELL LINE;
TUMOR GROWTH;
ANTINEOPLASTIC AGENTS;
CELL DIVISION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LOVASTATIN;
NEOVASCULARIZATION, PATHOLOGIC;
PYRIDINES;
SIMVASTATIN;
TUMOR CELLS, CULTURED;
|
|
EID: 0035902917
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(01)02736-3 Document Type: Letter |
|
Times cited : (14)
|
|
References (6)
|
